The Evolving Role of MRI in Prostate Cancer Management: Detection, Staging, Surveillance, Follow Up, and Reporting

Date: October 25, 2014 AND February 07, 2015
Annenberg Community Beach House
Santa Monica, California
The October 25, 2014 course has been combined with the February 7, 2015 course.
Prostate cancer is the second most common solid organ malignancy diagnosed in men. Unlike other solid organ malignancies, the challenge in prostate cancer is to confidently identify men with moderate and high grade cancers who would most benefit from aggressive therapy. Uniquely among solid organ cancers, imaging has not been a traditional part of the workup of prostate cancer, which has relied instead on transrectal US-guided template biopsy. Over the past few years, MR imaging has emerged as the best imaging modality to detect, grade and stage prostate cancer. This unique one-day course will provide a comprehensive overview of the utility of multiparametric MR imaging for comprehensive cancer care. We will discuss all relevant MR imaging parameters for prostate cancer (T2, perfusion, diffusion, and spectroscopy) and discuss new standardized MR reporting algorithms for prostate cancer. In conjunction with the UCLA Departments of Urology, Pathology, Nuclear Medicine, and Radiation Oncology, we will review application of MR imaging in surgical planning for robotic prostatectomy, prostate biopsy planning, active surveillance and radiation planning. We will also discuss state-of-the-art MR/US fusion biopsy and direct MR-guided biopsy planning. The course will also include an opportunity for participants to interact with industry partners.
February 7, 2015
For more information visit the CME web site.